Shri Kartikeya Pharma

KSM-66 was developed over 14+ years of R&D. We are widely recognized to be the ashwagandha expert and ashwagandha is the only thing we do. KSM-66 has been on the market for just over 10 years, but it is already in more than 1600 products, many from major supplement companies across the globe like Pfizer, W...

Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pertaining to regulations, quality control, supply chain disruptions, and sustainability efforts. 

The brochure includes the synopsis of our 26 published clinicals and 24 ongoing clinicals.

Steeped in centuries of tradition, natural extract products and herbal treatments still face numerous challenges when entering the commercial market. Inconsistent regulations, quality control oversight, and sustainable sourcing and procurement are among some of the top concerns for the pharmaceutical and nutraceutical industries. Despite these hurdles, natural extract products are shaping up to be pharma’s next big opportunity for investment as consumers look to take control of their own health with traditional herbal ingredients. Ashwagandha, in particular, is a trending extract boasting several health benefits against stress, sexual dysfunction, and increasing endurance. Our latest Trend Report, created in partnership with KSM-66 Ashwagandha, explores the potential of Ashwagandha root extract in consumer healthcare markets, and how the pharmaceutical and nutraceutical industries can work together to overcome obstacles within the Ashwagandha supply and value chain. Register to download your free Trend Report now.